Permanently Discontinued

APO-LEVOBUNOLOL OPHTHALMIC SOLUTION USP 0.25%

APOTEX INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is APO-LEVOBUNOLOL OPHTHALMIC SOLUTION USP 0.25% discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that APO-LEVOBUNOLOL OPHTHALMIC SOLUTION USP 0.25% has been permanently discontinued (last updated October 5, 2017). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Can I still get this?Check with your pharmacist

StatusPermanently Discontinued

Same-ingredient products on fileNone found

Affected strength0.25%

Report last updated2017-10-05

Checked by MedShort2026-11-12

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02241575

Strength

0.25%

Dosage Form

LIQUID

Route

OPHTHALMIC

Active Ingredient

LEVOBUNOLOL HYDROCHLORIDE

See all LEVOBUNOLOL HYDROCHLORIDE products →

Compare with another product →

Product Monograph

Product monograph is not available from Health Canada

View official Health Canada drug record ↗

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History

2017-10-05

Active Shortage

Other (Please describe in comments)

Other Products from APOTEX INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

24HR NASAL ALLERGY RELIEF

50MCG · DIN 02460513

ACETAMINOPHEN CAPLETS 325 MG

325MG · DIN 02362341

ACETAMINOPHEN CAPLETS 500 MG

500MG · DIN 02362368

ACETAMINOPHEN HEADACHE ULTRA RELIEF

DIN 02290901

ACETAMINOPHEN TABLETS USP 325 MG

325MG · DIN 02362422

ACETAMINOPHEN TABLETS USP 500 MG

500MG · DIN 02362244